Brief: Homology Medicines Appoints Albert Seymour as Chief Executive Officer
06/09/2022 22:13
Sept 6 (Reuters) - Homology Medicines Inc FIXX.O :
* HOMOLOGY MEDICINES APPOINTS ALBERT SEYMOUR, PH.D., CHIEF
EXECUTIVE OFFICER
* HOMOLOGY MEDICINES INC - ARTHUR TZIANABOS, PH.D., NAMED
CHAIRPERSON OF BOARD OF DIRECTORS
Source text for Eikon: ID:nGNX92BGfB
Further company coverage: FIXX.O
Recent news on Q32 Bio
See all newsNASDAQ RESUMED AT 09:35 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:30 AM
Brief: Q32 Bio Reports Second Quarter 2026 Financial Results And Provides Corporate Update
Q32 Bio Inc. reports results for the quarter ended June 30 - Earnings Summary
Q32 Bio Inc expected to post a loss of 54 cents a share - Earnings Preview